Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

after catheter ablation procedures for atrial fibrillation. Also Read: Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday? The updates emphasize the risk of atrio ...

Boston Scientific ... system is not safe and effective, if used in accordance with the instructions for use,” the society’s alert to doctors said. Cryoablation and radiofrequency ablation ...

1 Early clinical studies suggest that PFA performs similarly to thermal ablation in terms of acute-term and medium-term efficacy, with purported safety and efficiency advantages.2 The FARAPULSE system ...

Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...